Mark Froimson
Orthopaedic Surgery · Cleveland, OHNPI 1386680213
Payments from drug & device makers
What this record shows
The money is spread across several categories — ownership interests (54.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Pacira Pharmaceuticals Incorporated accounts for 95.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $568,249 and has fallen 50.6% since, to $280,492 in 2025. Among orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $13,415 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$2.3M
- Orthalign Inc$71K
- UOC USA Inc$37K
- Pacira Therapeutics, Inc.$14K
- Smith+Nephew$1K
- KCI USA, Inc.$555
- plus $63 from 1 others
Across 8 payments — averaging $58,925 each. An ownership or investment interest held by the physician or an immediate family member.
- Lazurite Inc.$471K
What the payments were for
- Consulting fees$121,1065%
- Speaking & faculty fees$986,13640%
- Travel & lodging$11,0340%
- Food & beverage$6,2230%
- Gifts$3620%
- Ownership interest$1,330,15054%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 155 | $2,332,013 |
| Orthalign Inc | 11 | $70,500 |
| UOC USA Inc | 11 | $36,873 |
| Pacira Therapeutics, Inc. | 2 | $14,000 |
| Smith+Nephew | 1 | $1,006 |
| KCI USA, Inc. | 2 | $555 |
| Johnson & Johnson | 1 | $63 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$1,334,571
- Zilretta$168,728
- Iovera$154,728
- OrthAlign Plus System$70,420
- IOVERA SYSTEM$16,832
- U2, PSA, UTS, UTF, U-Motion II$14,760
- U2 Knee$10,800
- Conformity, U2, AiO, U-Motion II$7,200
- U2, PSA, UTF, UTS, CONFORMITY, U-MOTION II, U-Star II$1,536
- S2 Procedure Performance$1,006
How this compares
$2,455,011 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.
Other orthopaedic surgery in Cleveland
- Reuben GobezieCleveland$12M
- Wael BarsoumCleveland$8.9M
- Joseph IannottiCleveland$7.1M
- Anthony MiniaciCleveland$3.1M
- Kenneth GreeneCleveland$2.6M
- Robert MolloyCleveland$2.3M
- Eric RicchettiCleveland$2.1M
- Thomas MrozCleveland$1.3M
- Robert GillespieCleveland$672K
- George ThompsonCleveland$420K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.